Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > long haul vs short term

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Dec 06, 2024 3:20pm

246 Views

Post# 36349963

long haul vs short term

If TLT were only a bladder cancer company I would be nervous, mainly because having only one drug and one indication is a bit risky for a company.

However, the antiviral, vaccine and rutherrin (GBM, NSCLC) avenues are really exciting and promising.

I have not problem holding and waiting but I wish the company were more competent at raising funds as the ruvidar slowdowns and delays have impacted getting cash for moving rutherrin along.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal